atazanavir has been researched along with pl 100 in 1 studies
| Studies (atazanavir) | Trials (atazanavir) | Recent Studies (post-2010) (atazanavir) | Studies (pl 100) | Trials (pl 100) | Recent Studies (post-2010) (pl 100) |
|---|---|---|---|---|---|
| 75 | 1 | 37 | 7 | 0 | 1 |
| Protein | Taxonomy | atazanavir (IC50) | pl 100 (IC50) |
|---|---|---|---|
| Protease | Human immunodeficiency virus 1 | 0.0005 | |
| Protease | Human immunodeficiency virus 1 | 0.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dandache, S; Parkin, N; Schapiro, JM; Sévigny, G; Stranix, BR; Wainberg, MA; Wu, JJ; Yelle, J | 1 |
1 other study(ies) available for atazanavir and pl 100
| Article | Year |
|---|---|
In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1.
Topics: Antiviral Agents; Carbamates; Cell Line, Tumor; Cell Survival; Drug Resistance, Viral; Genotype; HIV Protease Inhibitors; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Mutation; Phenotype; Sulfonamides; Viral Proteins | 2007 |